BIOLIGANDS ApS: Financial statements 2019
CVR: 26603110
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
BIOLIGANDS ApS (CVR 26603110) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -3,029 and a net result of DKK -3,029 compared with DKK -7,229 the year before. Equity in the 2019 report amounted to DKK 93,215. The solvency ratio was 96.6%.
- Gross Profit
- DKK -3,029
- Profit/Loss
- DKK -3,029
- Equity
- DKK 93,215
- Total Assets
- DKK 96,506
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -3 t. | -3 t. | 93 t. | - |
| 2018 | - | -7 t. | -7 t. | 96 t. | - |
| 2017 | - | -5 t. | -5 t. | 103 t. | - |
| 2016 | - | -4 t. | -4 t. | 109 t. | - |
| 2015 | - | -11 t. | 27 t. | 113 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BIOLIGANDS ApS
BIOLIGANDS ApS is a Danish company of the type Anpartsselskab based in Odense SV, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named BIOLIGANDS ApS UNDER STIFTELSE. The management consists of Esben Nørgaard Flindt. The board consists of Rasmus Koefoed Petersen. The company's owners include Esben Nørgaard Flindt, Karsten Kristiansen and Hongbin Zhang. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -8,258 and a net result of DKK -7,129 compared with DKK -4,850 the year before. Equity in the 2025 report amounted to DKK 62,700.